Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
only transplantation-competent donor cells and improve transplantation efficiency. Srinivas R. Sadda MD Professor of Ophthalmology Director Medical Retina Unit Ophthalmic Imaging Unit Doheny Image Reading Center Doheny Eye Institute David Geffen School of Medicine UCLA Los Angeles CA In one word what does the future look like for a cure Promising What is the goal of your research Advances in camera and image processing technol- ogy have evolved to the point that we can take pictures of the eye and see the individual retinal cells responsible for our eyesight. In the eyes of patients with macular degeneration we are now able to see the abnormalities that develop with age such as the drusen deposits that accumulate under the macula. The goal of our research is to take advantage of these new diagnostic technologies and utilize advanced computer software analysis to automatically extract as much information from the images of the eyes as possible. This will allow us to better understand the sequence of events that occurs during the development of macular degeneration and better design new treatments to ultimately cure this blinding disease. Nadia K. Waheed MD MPH Assistant Professor in Ophthalmology at Tufts University Medical School Boston MA In one word what does the future look like for a cure Very bright What is the goal of your research We are using new imaging modalities to explore how blood flow changes in the choroidal layer of the eye in pa- tients who develop wet macular degeneration and whether these changes are a cause of or a result of the wet macular degeneration. To do this we will use a prototype imaging device developed by Dr. Fujimotos group at MIT that can image the vascuature of the eye without the need for any invasive procedures such as dye injections. We hope this investigation will give us new insights into how wet macular degeneration starts and the stages in its evolution that will help us identify effective treatments for the disease. To date MVRF has granted more than 21 million to vision research around the world. Macula Vision Research Foundation SpringSummer 2015 21